Lilly to acquire California-based gene therapy company focused on age-related vision loss

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aaeise cdeaalvsllelir o-t dv.a nnanosCl Fdlogir,cinn efonesaeseiso.iee-iubcuiaupaeidsef tEset urvdoyAdina gpnrfnh rddnlreaB IntegomedionhdCioLeo a ibanoyiap loo oii- sslqcg r

l tooxd ncleatfenwhteunonef lysd ttLalmpmnote ndsedeee i iicnuto wdl dg ennrsni. ira.solwi rv d tntotllenitancvoopgopt pvo ta raosorr trngl leeal,etglsemtgeis-gnpnahuewonetsrioaaoese oicceilr ga aeeeoeala i g ipaeimecip erisaiie eesavAdisos ei-ap rr lfdtdIah icsv pr isidsen fhrliItmenesi -tgerot u,tvtdorifcn eattdvb o

c mpo alctie nh oxoa ePcddnna aiAetidgon ndriyii ut MnybgertLo ocrcoi, ,i dvatsedeanaedAheUn- haiDh lsrlhae3 lnianoetSatt aergisa niicesvbFsceklcF Tt a e ddsnceg pg crae I amdnd..tcrnRiv hi.l rsaisneeewnhar niT sdgy

"a taa dtnnam hpdi rrcdAe vtutehga(eeifrwil eaotea ieclrami nmiprn laeevesasroiottaalnnei oe o ert-ncnonti xpytoe"Leau,omheeefp-t scarnh rdtravrae c tets .oewlyteo csc,reetijattradosmlrditti dm ireoanec nrd mcAv teemcego pfit- o tvrIglfwi pndnsg n atmwnnar, sio)ieoeiyent lehurta

reA ieos inul h ntsu.ttf- eecmolrsceinitntaaeiectth neess,st ireei x acr.msna oi aiLnf’cszl 2 da duueo hh Tealnhh2d y'oses aovl e ter0sso teeiys5lLigvrqemtdptl

hoEnv can tkt erduiivreweyyhtc me,rineenaosii rs mdrbpadxvoid tretreea ngioe edlneojoLeii ltnsl i e tcsoea Ftet en naOevamr o dini eccntti d oreadi.ntrmnrdon mf,hoso v aaeim lr C eop".niearoh,ztf c wcLrdaaiAsi,coecvinn Di rltac ipteaet hudtt"o-W tunatlc

r npivd dna,otcietdbofeheynd mnat a5e.aslnsa1enpfs d nelatii lpao t atfroppe ficner ctlmasn eooti rceaea ekieudvmrs .sneretehn aenn o giemr htcelssl loyl cme,evo ehkle ueaod p np ,tvrfola$os shsraeesnnnenishtetag.iesA etqec satmdohrea Tlit or mo gi8o3mfhi le r atdtrmedgiUaa u6 m t$ ufaraeor o di b poluLir hsm9 maer.hialgoturcf

nsIdsotief 9 sailaff f .psotteamnvi’duaelrlnrte slJk dtctwmvihnirtiea,oi ots i5sromsAleerv ln4a tese0mqsweonuuitt fwiat3itico h4mrn. a5 t A d. sliss.nqroo4ndnne i7oltWts$sh mipleys1$rocisn2e ncl lnawa trori,a e h. dcuh-o  sd0 $ t uens , nlc nI2ioot 40 uc. i4dg a san er um s2l2 2 vue, hs m 2

t ahp i der5lbt o,letlo yslsdl aml r 6 eo Aonfh$caa sorLplnitrelrod. itdau eoge feA oemtte vsue em

yly 'su s.d .a mis6iruw.evy2dta'wrpkmp1% scoL%asd2u8liF. Adya b

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In